BullFrog AI to Introduce New AI Capability for Pharmaceutical Portfolio Strategy and Clinical Trial Design

BullFrog AI is launching a new precision AI capability on March 25, which advances its end-to-end AI intelligence workflow with a scenario-based decision engine. This technology bolsters current AI decision tools by clearly defining clinical trial strategies and building diversified, risk-balanced R&D portfolios. The new capability compares drug programs and trial designs without forcing arbitrary numerical scores and identifies options that perform well across strategic futures.